Recombinant anti-mouse PD 1 / PD L1 bispecific antibodies share the variable region sequences with the rat anti-mouse PD-1 antibody (clone number: 29F.1A12) and the rat anti-mouse PD-L1 antibody (clone number: 10F.9G2). The recombinant mouse...
Recombinant anti-mouse PD 1 / PD L1 bispecific antibodies share the variable region sequences with the rat anti-mouse PD-1 antibody (clone number: RMP1-14) and the rat anti-mouse PD-L1 antibody (clone number: 10F.9G2). The recombinant mouse...
Recombinant anti-mouse PD 1 / PD L1 bispecific antibodies share the variable region sequences with the rat anti-mouse PD-1 antibody (clone number: RMP1-14) and the rat anti-mouse PD-L1 antibody (clone number: 10F.9G2). The recombinant mouse...
Recombinant anti-mouse PD 1 / PD 1 bispecific antibodies share the variable region sequences with the rat anti-mouse PD-1 antibody (clone number: RMP1-14) and the rat anti-mouse PD-1 antibody (clone number: 29F.1A12). The recombinant mouse...
Recombinant mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant mouse IgG2b isotype control, Recombinant mouse IgG2c LALAPG isotype control, and Recombinant mouse IgG2a LALAPG isotype control are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant rat IgG2b isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
In vivo Grade Recombinant Anti-mouse CD3e Mouse IgG2a Kappa Monoclonal Antibody (Clone: 500A2). Isotype: Mouse IgG2a kappa. Purity: >95%.
Recombinant rat IgG2b isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant mouse IgG2b isotype control, Recombinant mouse IgG2c LALAPG isotype control, and Recombinant mouse IgG2a LALAPG isotype control are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
